China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'RealTime Predictive Value of Baseline and Dynamic Changes in Peripheral Blood Inflammatory Markers (NLR, PLR, SIRI) for Efficacy and Prognosis in Advanced NSCLC Receiving FirstLine Immunotherapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133592
Registration Time: 2026/09/29
Type: Observational study
Primary Sponsor: Yuebei People’s Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344194
Published by HT Digital Content Services with permission from Health Daily Digest....